Polaris Peptides
- 3 compounds tested
- Registered Jan 2024
- COAs on file
- 4
- Independently confirmed
- 0
- Median purity
- 99.87%
- At or above market
- 3/3
- Most recent
- 14 May
across 2 labs
none on record
▲ 0.21 vs corpus
compounds comparable
4 months ago
polarispeptides.com · registered 2024 · 2y 8m old · transfer-locked · registry checked 29 Jul 2026Registry detail
- Registered
- 7 Jan 2024
- Registry expiry
- 7 Jan 2027
- Record last changed
- 9 Dec 2025
- EPP status
- client transfer prohibited, client update prohibited
- Source
- RDAP registry
- First indexed by us
- 17 Apr 2026
Research use only. This vendor supplies peptides for laboratory and research purposes — not for human consumption or therapeutic use. PeptideBase does not endorse or guarantee product quality. Verify third-party lab testing before any research use.
Vendor-supplied · Not verified by PeptideBase
What this vendor publishes about itself, repeated here. Disclosure is not verification; only independent lab results change that.
4 certificates on file, all self-published by the vendor. Median purity 99.87%, against 99.66% across all 1,295 certificates we score. Three of three compounds test at or above their market median. The exception is a Tirzepatide lot at 99.60% — 0.21 points below the 99.81% median for that compound.
Evidence provenance
- 4 self-published
- COAs the vendor posted on their own site.
Recorded for completeness. A self-published document doesn't count as confirmed on its own — the document is real, the chain of custody isn't independent.
Purity vs market
4 of 4 results sit within ±0.4 points of their market median.
Lab testing record
Every COA we hold for Polaris Peptides.
How these certificates can be checked
Of the 4 certificates we hold for Polaris Peptides:
- 2No lookup reference on the report
- 2Lab lookup not established
These do not all sit in the same state, so no single statement covers them. Each certificate below says which applies to it.
| Panel | Source | Reference | |||||
|---|---|---|---|---|---|---|---|
| Tirzepatide | BTLabs | 14 May 26 | 99.60% | −0.21 | — | Self-published | View COA ↗ |
| We have not established whether BTLabs publishes a report lookup. | |||||||
| NAD+ | BTLabs | 17 Mar 26 | 99.90% | +0.33 | — | Self-published | View COA ↗ |
| We have not established whether BTLabs publishes a report lookup. | |||||||
| BPC-157 | TrustPointe Analytics LLC | 25 Apr 25 | 99.84% | +0.28 | — | Self-published | View COA ↗ |
| TrustPointe Analytics LLC publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| Tirzepatide | TrustPointe Analytics LLC | 21 Apr 25 | 99.89% | +0.08 | — | Self-published | View COA ↗ |
| TrustPointe Analytics LLC publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
The labs behind these results
In the vendor's own words
Written by the vendor · Not verified by PeptideBase
US-based research peptide vendor with a Finnrick A rating and a catalog of 23+ compounds. Polaris Peptides provides certificates of analysis and third-party laboratory testing for its full product range, which includes BPC-157, TB-500, IGF-1 LR3, CJC-1295, Ipamorelin, Tirzepatide, Retatrutide, GHK-Cu, and PT-141. Products are available for in vitro and laboratory research use only and are not intended for human consumption or clinical application.
#Testing disclosure
- Publishes COAsVendor-stated
- Not observed
- COA accessVendor-stated
- Not established
- Last observedOur record
- 6 Jul 2026
- Batch numbers shownOur record
- Yes
Research pricing
| Compound | Price | Size | $/mg | vs tracked range | SKUs |
|---|---|---|---|---|---|
| AOD-9604 | $40.00 | 2 mg | $20.00 | $7.78$14.20 | 1 |
| BPC-157 | $60.00 | 10 mg | $6.00 | $4.40$7.63 | 2 |
| Cagrilintide | $140.00 | 10 mg | $14.00 | $8.00$15.00 | 2 |
| CJC-1295 (without DAC) | $60.00 | 10 mg | $6.00 | $6.80$11.50 | 1 |
| DSIP | $40.00 | 5 mg | $8.00 | $4.67$8.34 | 1 |
| Epithalon | $125.00 | 50 mg | $2.50 | $2.21$4.24 | 2 |
| GHK-Cu | $35.00 | 50 mg | $0.70 | $0.55$1.00 | 3 |
| IGF-1 LR3 | $50.00 | 10 mg | $5.00 | no market range | 1 |
| Ipamorelin | $50.00 | 10 mg | $5.00 | $5.00$8.60 | 1 |
| LL-37 | $125.00 | 10 mg | $12.50 | $8.00$15.20 | 1 |
| MOTS-c | $55.00 | 10 mg | $5.50 | $3.25$6.20 | 1 |
| PT-141 | $40.00 | 10 mg | $4.00 | $3.17$5.27 | 2 |
| Retatrutide | $400.00 | 60 mg | $6.67 | $5.61$9.57 | 4 |
| Semaglutide | $165.00 | 20 mg | $8.25 | $5.92$13.43 | 5 |
| Sermorelin | $75.00 | 10 mg | $7.50 | $6.83$10.95 | 1 |
| SS-31 | $129.00 | 25 mg | $5.16 | $3.85$7.00 | 2 |
| TB-500 | $70.00 | 10 mg | $7.00 | $5.18$9.70 | 1 |
| Tesamorelin | $65.00 | 10 mg | $6.50 | $6.66$11.74 | 1 |
| Thymosin Alpha-1 | $65.00 | 10 mg | $6.50 | $6.50$9.92 | 1 |
| Thymulin | $40.00 | 10 mg | $4.00 | no market range | 1 |
| Tirzepatide | $129.99 | 10 | $1.30 | $4.24$8.08 | 5 |
Research catalog
Add this badge to your website
Profile last updated
Cite this page
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). Polaris Peptides — Research Vendor Profile. Retrieved October 1, 2026, from https://peptidebase.io/research-vendors/polaris-peptides